TABLE 1.
Apo | Peptide Sequence | Fragment | Cone/Collision (V) | MRM Transition (m/z) | Retention Time (min) |
ApoA-I | |||||
M0 | ATEHLSTLSEK | y6+ | 30/25 V | 608.3 → 664.3 | 1.6 ± 0.1 |
M3 | ATEH L ST L SEK | 609.8 → 664.3 + 667.3 | |||
IS | ATEHLSTLSEK | 612.3 → 672.3 | |||
ApoA-II | |||||
M0 | SPELQAEAK | y6+ | 30/30 V | 486.8 → 659.3 | 1.4 ± 0.1 |
M3 | SPE L QAEAK | 488.3 → 662.3 | |||
IS | SPELQAEAK | 490.3 → 667.3 | |||
ApoB100 | |||||
M0 | NLQNNAEWVYQGAIR | y6+ | 50/30 V | 888.5 → 707.4 | 2.7 ± 0.1 |
M3 | N L QNNAEWVYQGAIR | 890.0 → 707.4 | |||
IS | NLQNNAEWVYQGAIR | 893.5 → 717.4 | |||
ApoC-II | |||||
M0 | TAAQNLYEK | y4+ | 80/30 V | 1,037.9 → 552.3 | 1.4 ± 0.1 |
M3 | TAAQN L YEK | 1,040.9 → 555.3 | |||
IS | TAAQNLYEK | 1,045.9 → 560.3 | |||
ApoC-III | |||||
M0 | DALSSVQESQVAQQAR | y8+ | 40/35 V | 858.9 → 887.5 | 2.0 ± 0.1 |
M3 | DA L SSVQESQVAQQAR | 860.4 → 887.5 | |||
IS | DALSSVQESQVAQQAR | 863.4 → 897.5 | |||
ApoE | |||||
M0 | LGPLVEQGR | y5+ | 25/30 V | 484.8 → 588.3 | 2.1 ± 0.1 |
M3 | L GP L VEQGR | 486.3 → 588.3 | |||
IS | LGPLVEQGR | 489.3 → 598.3 |
Underlined L indicates the putative incorporation site(s) of 2H3-leucine. Bold indicates the labeled amino acid [13C6, 15N2]K or [13C6, 15N4]R. IS, internal standard.